Group One Trading
IOVA icon

Group One Trading’s Iovance Biotherapeutics IOVA Stock Holding History

Group One Trading’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$989K Sell
237,671
-358,085
-60% -$1.36M ﹤0.01% 2886
2026
Q1 		$2.09M Buy
595,756
+427,079
+253% +$1.37M ﹤0.01% 2035
2025
Q4 		$460K Sell
168,677
-261,177
-61% -$604K ﹤0.01% 3609
2025
Q3 		$933K Sell
429,854
-123,614
-22% -$292K ﹤0.01% 3109
2025
Q2 		$952K Buy
553,468
+77,667
+16% +$193K ﹤0.01% 2813
2025
Q1 		$1.58M Sell
475,801
-1,220,500
-72% -$6.29M ﹤0.01% 2040
2024
Q4 		$12.6M Buy
1,696,301
+413,333
+32% +$3.83M 0.03% 577
2024
Q3 		$12M Buy
1,282,968
+551,361
+75% +$5.22M 0.03% 509
2024
Q2 		$5.87M Buy
731,607
+243,569
+50% +$2.61M 0.02% 711
2024
Q1 		$7.23M Sell
488,038
-88,264
-15% -$1.03M 0.03% 591
2023
Q4 		$4.69M Sell
576,302
-49,399
-8% -$258K 0.01% 1200
2023
Q3 		$2.85M Buy
625,701
+523,723
+514% +$3.42M 0.01% 1352
2023
Q2 		$718K Buy
101,978
+41,747
+69% +$299K ﹤0.01% 2659
2023
Q1 		$368K Sell
60,231
-70,444
-54% -$486K ﹤0.01% 3050
2022
Q4 		$835K Buy
130,675
+65,137
+99% +$509K ﹤0.01% 2590
2022
Q3 		$628K Sell
65,538
-54,984
-46% -$634K ﹤0.01% 3010
2022
Q2 		$1.33M Buy
120,522
+119,451
+11,153% +$1.57M ﹤0.01% 2458
2022
Q1 		$18K Sell
1,071
-31,864
-97% -$493K ﹤0.01% 6820
2021
Q4 		$629K Sell
32,935
-126,809
-79% -$2.79M ﹤0.01% 3857
2021
Q3 		$3.94M Buy
+159,744
New +$3.76M ﹤0.01% 1952
2021
Q2 		– Sell
-14,035
Closed -$365K – 8331
2021
Q1 		$444K Buy
+14,035
New +$582K ﹤0.01% 4186
2020
Q4 		– Sell
-46,117
Closed -$1.83M – 6724
2020
Q3 		$1.52M Buy
+46,117
New +$1.41M ﹤0.01% 1826
2019
Q3 		– Sell
-13,634
Closed -$302K – 5329
2019
Q2 		$334K Buy
+13,634
New +$205K ﹤0.01% 2499
2019
Q1 		– Sell
-15,403
Closed -$150K – 5062
2018
Q4 		$136K Buy
+15,403
New +$149K ﹤0.01% 2969
2018
Q3 		– Sell
-7,045
Closed -$100K – 5381
2018
Q2 		$90K Buy
+7,045
New +$103K ﹤0.01% 3627
2017
Q4 		– Sell
-122
Closed -$980 – 5009
2017
Q3 		$1K Sell
122
-4,080
-97% -$25.8K ﹤0.01% 4704
2017
Q2 		$31K Sell
4,202
-1,398
-25% -$8.89K ﹤0.01% 3754
2017
Q1 		$42K Buy
5,600
+1,316
+31% +$9.65K ﹤0.01% 3508
2016
Q4 		$30K Sell
4,284
-12,346
-74% -$85K ﹤0.01% 3526
2016
Q3 		$137K Sell
16,630
-1,042
-6% -$8.81K ﹤0.01% 2738
2016
Q2 		$143K Buy
17,672
+11,918
+207% +$74.8K ﹤0.01% 2629
2016
Q1 		$29K Buy
+5,754
New +$31.5K ﹤0.01% 3551
2015
Q4 		– Sell
-45,978
Closed -$319K – 4891
2015
Q3 		$265K Buy
45,978
+12,472
+37% +$97.1K ﹤0.01% 2295
2015
Q2 		$307K Buy
+33,506
New +$374K ﹤0.01% 2208

Other funds holding IOVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Group One Trading's IOVA Position: Q2 2026 in Review

Group One Trading reduced its Iovance Biotherapeutics (IOVA) stake by 60% in Q2 2026, selling an estimated $1.36M and leaving 237,671 shares worth $989K. The position accounts for ﹤0.01% of the portfolio, ranked #2886.

Group One Trading first reported a position in IOVA in Q2 2015 and has held it in 34 quarters since. The position peaked at $12.6M in Q4 2024. 292 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

  • Group One Trading held 237,671 shares of Iovance Biotherapeutics worth $989K as of Q2 2026.
  • Group One Trading sold 358,085 Iovance Biotherapeutics shares in Q2 2026, an estimated $1.36M.
  • Iovance Biotherapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #2886 holding.
  • Group One Trading first reported a position in Iovance Biotherapeutics in Q2 2015 and has held it in 34 quarters since.
  • Group One Trading's Iovance Biotherapeutics position peaked at $12.6M in Q4 2024.
  • 292 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.